person

Hans S.

Country
Germany
Department
Onkologie, Hämatologie, Palliativmedizin, Rheumatologie und Pneumologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
290
Sites with multiple studies

Has run more than one trial at 290 of 538 partner sites.

Specializations

Multiple Myeloma Research

This investigator specializes in researching novel therapeutic approaches for multiple myeloma, with particular emphasis on both newly diagnosed and relapsed/refractory cases. The research encompasses innovative treatment combinations using monoclonal antibodies and targeted therapies.

  • Newly Diagnosed Multiple Myeloma
  • Relapsed/Refractory Multiple Myeloma
  • Immunotherapy Combinations

The work includes evaluation of various therapeutic combinations incorporating isatuximab, elranatamab, and daratumumab.

Hematologic Malignancies

The investigator conducts research in various blood cancers, with expertise in acute myeloid leukemia and myelodysplastic syndromes. The focus includes development of novel treatment strategies and combination approaches.

  • Acute Myeloid Leukemia
  • Lymphoma Studies
  • Stem Cell Transplantation

Research includes evaluation of intensive chemotherapy protocols and targeted therapies.

Clinical Innovation

The investigator leads research in treatment optimization and drug delivery methods, including comparative studies of intravenous versus subcutaneous administration routes.

  • Drug Administration Methods
  • Treatment Response Assessment
  • Minimal Residual Disease Evaluation

Focus includes development of maintenance therapy strategies and evaluation of treatment combinations.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.